U.S. Stem Cell Competitors and Similar CompaniesClear all

U.S. Stem Cell's competitors and similar companies include Bio Farma, Shandong Saito Biotechnology, The Searle Company and Plasma Industries.

	U.S. Stem Cell U.S. Stem Cell is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.	Bio Farma Bio Farma is a manufacturer of vaccines.	Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.	The Searle Company The Searle Company is a pharmaceutical company.	Plasma Industries Plasma Industries is a pharmaceutical company.
Founding Date	Founding Date N/A	Founding Date 1890	Founding Date 2010	Founding Date 1965	Founding Date 1951
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development	Tags Healthcare biotech drug development
Locations	Locations Sunrise, US HQ Sunrise, US	Locations ID HQ	Locations Heze, CN HQ	Locations Karachi, PK HQ Karachi, PK Karachi, PK Lahore, PK	Locations Brussel, BE HQ Buggenhout, BE
Employees	Employees 10	Employees 1,233	Employees 95920% decrease	Employees 2,4241% increase	Employees 6761% increase
Valuation ($)	Valuation ($) 64.2 k	Valuation ($) N/A	Valuation ($) 708.6 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $82k (FY, 2022)	Revenue (est.) N/A	Revenue (est.) ¥961.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $23.8k (FY, 2022)	Cost of goods N/A	Cost of goods ¥864.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $58.3k (FY, 2022)	Gross profit N/A	Gross profit ¥140.3m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($2.9m) (FY, 2022)	Net income N/A	Net income (¥84.7m) (FY, 2025)	Net income N/A	Net income N/A